Evidence map›Paper›PMID 41426483›Full record

ReviewFrontiers in sleep2023

Innovations in mandibular advancement splint therapy for obstructive sleep apnoea.

Anna Mohammadieh, Benjamin Tong, Philip De Chazal, Peter A Cistulli

Abstract readReview
In one paragraph

Review in Frontiers in sleep, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anna MohammadiehDepartment of Respiratory and Sleep Medicine, Royal North Shore Hospital, Sydney, NSW, Australia.
Benjamin TongDepartment of Respiratory and Sleep Medicine, Royal North Shore Hospital, Sydney, NSW, Australia.
Philip De ChazalCharles Perkins Centre, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Peter A CistulliDepartment of Respiratory and Sleep Medicine, Royal North Shore Hospital, Sydney, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mandibular advancement splint (MAS) therapy emerged as an effective therapy for obstructive sleep apnoea (OSA) in the mid 1990s, and is now the leading treatment alternative for OSA. Since its inception, the field has seen a suite of revisions and advances in relation to design and customisation, fabrication, titration methods, response prediction models and the integration of data collection technology. This paper reviews these current and emerging innovations in MAS therapy and their impact upon sleep apnoea management.

Indexed as

mandibular advancement devicemandibular advancement splintobstructive sleep apnoeaoral appliancesleep apnoea

Identifiers

PMID41426483
PMCPMC12713823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.